TWO TREATMENT APPROACHES FOR HUMAN REGULAR U-500 INSULIN IN PATIENTS WITH TYPE 2 DIABETES NOT ACHIEVING ADEQUATE GLYCEMIC CONTROL ON HIGH-DOSE U-100 INSULIN THERAPY WITH OR WITHOUT ORAL AGENTS: A RANDOMIZED, TITRATION-TO-TARGET CLINICAL TRIAL

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Volumn 21, Issue 7, 2015, Pages 782-793

  Hood, Robert C ^a   Arakaki, Richard F ^a   Wysham, Carol ^a   Li, Ying G ^a   Settles, Julie A ^a   Jackson, Jeffrey A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; HUMAN INSULIN;

BLOOD; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN, REGULAR, HUMAN; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84979798551     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP15612.OR     Document Type: Article

References (0)